Use of Complementary and Alternative Medicine by Patients Treated for Systemic Lupus Erythematosus, Primary Sjögren's Syndrome, or Systemic Sclerosis in a French Rural Region

被引:0
|
作者
Couillard, Florence [1 ]
Parreau, Simon [1 ]
Dumonteil, Stephanie [1 ]
Ratti, Nina [1 ]
Palat, Sylvain [1 ]
Bezanahary, Holy [1 ]
Liozon, Eric [1 ]
Ly, Kim-Heang [1 ]
Fauchais, Anne-Laure [1 ]
Gondran, Guillaume [1 ]
机构
[1] Dupuytren Univ Hosp, Internal Med, Limoges, France
关键词
Complementary and alternative medicine; Autoimmune diseases; Lupus; Systemic sclerosis; Sj & ouml; gren's syndrome; French rural region; PRIMARY SJOGRENS-SYNDROME; RHEUMATOLOGY/EUROPEAN LEAGUE; CLASSIFICATION CRITERIA; AMERICAN-COLLEGE; ACUPUNCTURE; THERAPIES;
D O I
10.1159/000536580
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Complementary and alternative medicine (CAM) is composed of a wide range of interventions and frequently used in parallel with conventional medicine. The aim of this study was to assess the prevalence, modalities, and association factors of CAM utilization in patients treated for systemic lupus erythematosus, primary Sj & ouml;gren's syndrome, or systemic sclerosis. Patients and Methods: This was a prospective single-center observational study conducted in a French university hospital center. Inclusion criteria were patients followed for systemic lupus erythematosus, primary Sj & ouml;gren's syndrome, or systemic sclerosis. Data were collected with a survey which assessed sociodemographic, disease characteristics, CAM use details, life quality, and anxiety score. Results: A total of 121 patients were included, mostly women (87%), with an average age of 56 years. Proportion of patients seeking CAM was 55%. A total of 186 CAM interventions were recorded: most common were osteopathy, homeopathy, and acupuncture. Patients were looking for well-being (22%), reducing their fatigue (18%) and pain (33%). Concerning physical and mental feeling after CAM use, a subjective improvement was reported in 89% of cases. In multivariate analysis, CAM use by patient was associated with these 3 variables: coming from a Western culture, being professionally active, and having a poor quality of life and anxiety scores. Conclusion and Outlook: This is the first study to focus on CAM use in patients followed for three AID in a French rural region. The current challenge is to enrich conventional medicine with CAM that is effective and safe through supervised programs to move toward an integrative medicine. Hintergrund: Die Komplement & auml;r- und Alternativmedizin (CAM) umfasst ein breites Spektrum an Interventionen und wird h & auml;ufig parallel zur konventionellen Medizin angewendet. Das Ziel dieser Studie war die Beurteilung der Pr & auml;valenz, Modalit & auml;ten und Assoziationsfaktoren der CAM-Anwendung bei Patienten, die wegen systemischem Lupus erythematodes, prim & auml;rem Sj & ouml;gren-Syndrom oder systemischer Sklerose behandelt werden.Patienten und Methoden: Es handelte sich um eine prospektive monozentrische Beobachtungsstudie, die an einem franz & ouml;sischen Universit & auml;tsklinikum durchgef & uuml;hrt wurde. Eingeschlossen wurden Patienten, die dort wegen systemischem Lupus erythematodes, prim & auml;rem Sj & ouml;gren-Syndrom oder systemischer Sklerose in Behandlung waren. Die Datenerhebung erfolgte mittels eines Fragebogens, der soziodemografische Merkmale, Krankheitsmerkmale, Einzelheiten der CAM-Anwendung, Lebensqualit & auml;t- und Angst-Scores umfasste.Ergebnisse: Insgesamt wurden 121 Patienten randomisiert, & uuml;berwiegend Frauen (87%); das Durchschnittsalter betrug 56 Jahre. Der Anteil der Patienten, die CAM w & uuml;nschten, betrug 55%. Insgesamt 186 CAM-Interventionen wurden erfasst; am h & auml;ufigsten Osteopathie, Hom & ouml;opathie und Akupunktur. Den Patienten ging es dabei um das Wohlbefinden (22%) sowie die Linderung von M & uuml;digkeit (18%) und Schmerzen (33%). Hinsichtlich des physischen und psychischen Befindens nach der CAM-Anwendung berichteten 89% der Befragten & uuml;ber eine subjektiv empfundene Verbesserung. In multivariaten Analysen war die CAM-Anwendung pro Patient mit den folgenden 3 Variablen assoziiert: aus einer westlichen Kultur stammend, berufst & auml;tig sowie schlechte Lebensqualit & auml;t- und Angst-Scores.Zusammenfassung und Ausblick: Dies ist die erste Studie zur CAM-Anwendung bei Patienten, die im l & auml;ndlichen Raum in Frankreich wegen einer von drei Autoimmunerkrankungen behandelt werden. Die aktuelle Herausforderung lautet, der konventionellen Medizin in supervidierten Programmen wirksame und sichere CAM-Interventionen an die Seite zu stellen, um zu einer integrativen Medizin zu gelangen.
引用
收藏
页码:234 / 240
页数:7
相关论文
共 50 条
  • [41] Fatigue in daily life in patients with primary Sjogren's syndrome and systemic lupus erythematosus
    Godaert, GLR
    Hartkamp, A
    Geenen, R
    Garssen, A
    Kruize, AA
    Bijlsma, JWJ
    Derksen, RHWM
    [J]. NEUROENDOCRINE IMMUNE BASIS OF THE RHEUMATIC DISEASES II, PROCEEDINGS, 2002, 966 : 320 - 326
  • [42] The role of exercise in the rehabilitation of patients with systemic lupus erythematosus and patients with primary Sjogren's syndrome
    Strombeck, Britta
    Jacobsson, Lennart Th.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2007, 19 (02) : 197 - 203
  • [43] A case of overlap syndrome with rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis and secondary Sjogren's syndrome
    Turkcapar, Nuran
    Olmez, Umit
    Ozer, Didem
    Duzgun, Nursen
    Duman, Murat
    [J]. RHEUMATOLOGY INTERNATIONAL, 2006, 26 (09) : 841 - 845
  • [44] The association between hydroxychloroquine use and future development of systemic lupus erythematosus in patients with primary Sjogren's syndrome
    Hsu, Bo-Chueh
    Chen, Yi-Hsing
    Lin, Ching-Heng
    Tang, Kuo-Tung
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (12) : 1424 - 1430
  • [45] Citrullinated antibodies in systemic lupus erythematosus and primary Sjogren's syndrome
    Hullo, D.
    Szoeke, L.
    Szollosl, I
    Balog, A.
    Sonkodi, G.
    Lele, K.
    Torok, E.
    Kovacs, L.
    Zeher, M.
    Sipka, S.
    Pokorny, G.
    [J]. 2ND EUROPEAN CONGRESS OF IMMUNOLOGY (ECI), 2009, : 309 - +
  • [46] Antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome
    Salcido-Ochoa, F
    Cabiedes, J
    Alarcón-Segovia, D
    Cabral, AR
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2002, 8 (05) : 251 - 255
  • [47] COGNITIVE DYSFUNCTION IN PRIMARY SJOGREN'S SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS
    Garza Martinez, M. J.
    Trevino-Castro, M. A.
    Hernandez-Galarza, I. D. J.
    Cardenas, A.
    Pineda, R.
    Solis, C. V.
    Riegatorres, J. C.
    Skinner Taylor, C. M.
    Galarza-Delgado, D. A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1501 - 1502
  • [48] Genetic variants of chemokine receptor CCR7 in patients with systemic lupus erythematosus, Sjogren's syndrome and systemic sclerosis
    Daniel Kahlmann
    Ana Clara Marques Davalos-Misslitz
    Lars Ohl
    Frauke Stanke
    Torsten Witte
    Reinhold Förster
    [J]. BMC Genetics, 8
  • [49] Ocular and eyelid involvement in collagen vascular diseases. Part I. Sjögren syndrome and systemic lupus erythematosus
    Enwereji, Ndidi
    Santiago, Sueheidi
    Jiang, Christina
    Durrani, Khayyam
    Chaudhry, Sona
    Lu, Jun
    [J]. CLINICS IN DERMATOLOGY, 2024, 42 (01) : 3 - 8
  • [50] Genetic variants of chemokine receptor CCR7 in patients with systemic lupus erythematosus, Sjogren's syndrome and systemic sclerosis
    Kahlmann, Daniel
    Davalos-Misslitz, Ana Clara Marques
    Ohl, Lars
    Stanke, Frauke
    Witte, Torsten
    Foerster, Reinhold
    [J]. BMC GENETICS, 2007, 8 (1)